Skip to content
Avada ECO
  • Patients
  • Research
    • Parkinson’s disease
    • MSA (multiple system atrophy)
    • PD DETECT
    • Publications
  • Diagnostics laboratory
  • PD DETECT
  • About us
  • Press
  • EN
    • DE
Blog
Blog
MODAG
  • EN
    • DE
  • Patients
  • Research
    • Parkinson’s disease
    • MSA (multiple system atrophy)
    • PD DETECT
    • Publications
  • Diagnostics laboratory
  • PD DETECT
  • About us
  • Press
  • Blog
  1. Home
  2. Blog

Blog

  • Research
anle 138b
anle 138b
Categories: Press

MODAG Initiates First-in-Patient Phase 1b Trial for Anle138b in Parkinson´s Disease

Anle138b is a disease-modifying treatment option for synucleinopathies, such as Multiple System Atrophy (MSA) and PD.

weiterlesen
mikroforum
mikroforum
Categories: Press

MODAG Successfully Completes Phase 1 Study of their Lead Candidate Anle138b

and Receives Additional USD 1.4 Million from Michael J. Fox Foundation

weiterlesen
anle 138b
anle 138b
Categories: Press

MODAG Initiates First-in-Human Phase 1 Clinical Trial for Anle138b

Worldwide patent for anle138b secured

weiterlesen
BlogForge122025-09-26T14:34:22+02:00

  • Press

    MODAG Launches Out of Stealth Mode with Series A Financing of EUR 12 Million

    Artikel lesen
Previous23
E-mail: info@modag.net
Phone: +49-6734-9622-8000
Our research areas
  • Parkinson’s disease
  • MSA (multiple system atrophy)
Our research areas
  • Parkinson’s disease
  • MSA (multiple system atrophy)
Overview
  • About us
  • Patients
  • Research
  • Diagnostics laboratory
  • PD DETECT
General
  • Career
  • Press
  • Publications
  • Privacy Policy
  • Imprint

© 2026 MODAG GmbH | All Rights Reserved |

Page load link
Go to Top